Scientists have identified and modeled a distinct biology for pediatric AML
December 30, 2018
Researchers have just identified and developed a model for pediatric patients with pediatric acute leukemia (AML), one of the most lethal forms of cancer in children.
This new research, emerging from University of Glasgow’s Institute of Cancer Sciences, establishes a large degree of understanding of this disease. Furthermore, these findings open possibilities to develop specialized treatment plans for this form of cancer. Acute myeloid leukemia is one of the most deadly forms of pediatric cancer and, for children, relapse is often fatal. As determined in this experiment, pediatric AML displays a distinct gene profile when compared to adult AML, indicating that treatments specific for children must be pursued in the future.